Immunologically high-risk recipient strategies

被引:7
作者
First, MR [1 ]
机构
[1] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA
关键词
D O I
10.1016/S0041-1345(98)01520-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:243 / 246
页数:4
相关论文
共 26 条
[21]  
SCHROEDER TJ, 1989, AM J KIDNEY DIS, V14, P14
[22]   SEQUENTIAL ANTILYMPHOBLAST GLOBULIN AND CYCLOSPORINE FOR RENAL-TRANSPLANTATION [J].
SOMMER, BG ;
HENRY, M ;
FERGUSON, RM .
TRANSPLANTATION, 1987, 43 (01) :85-90
[23]  
TAKEMOTO S, 1996, CLIN TRANS, P417
[24]  
*UNOS RES DEP, 1998, UNOS UPD
[25]   Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation [J].
Vincenti, F ;
Kirkman, R ;
Light, S ;
Bumgardner, G ;
Pescovitz, M ;
Halloran, P ;
Neylan, J ;
Wilkinson, A ;
Ekberg, H ;
Gaston, R ;
Backman, L ;
Burdick, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (03) :161-165
[26]  
WHELCHEL JD, 1997, CLIN TRANSPLANTS 199, P249